USC researchers have developed an innovative type of cancer-fighting immune cell, the EchoBack CAR T-cell, that uses focused ultrasound to activate and sustain a powerful, targeted attack on tumors. Unlike earlier versions, these cells remain effective for days without tiring and only activate near cancer, reducing damage to healthy tissue.
